| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/22/2004 | US20040142452 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 07/22/2004 | US20040142449 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142446 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 07/22/2004 | US20040142445 Novel metalloprotease having aggrecanase activity |
| 07/22/2004 | US20040142444 Comprises nucleotide sequences coding glucanase for use in textile treatment, detergents, papermaking, wood pulping and enhancing animal feeds |
| 07/22/2004 | US20040142443 Comprises generating recombination polypeptide (RUVB) for use in controlling homologous recombination efficiency or transformation efficiency in plants |
| 07/22/2004 | US20040142441 Comprises polypeptide with lipolytic activities for in enhancing the processing of fats |
| 07/22/2004 | US20040142437 Isolated gene from arabidopsis; hybridization of nucleic acid, polypeptides |
| 07/22/2004 | US20040142435 Using genetically engineered methylophilus comprising enhanced 6-phosphogluconate dehydratase and/or 2-keto-3-dexoy-6-phosphogluconate aldolase activities to prepare lysine, leucine, isoleucine and valine; bioreactors |
| 07/22/2004 | US20040142434 Thermostable glucoamylase |
| 07/22/2004 | US20040142433 Polynucleotide sequence variants |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142430 Production of a multimeric protein by cell fusion method |
| 07/22/2004 | US20040142429 Using nickel-chelate chromatography to purifiy and recover hydrophobic proteins, polypeptides or peptides in non-aggregated form; lipid bilayer formation |
| 07/22/2004 | US20040142428 Mammalian cytokine-like polypeptide-10 |
| 07/22/2004 | US20040142427 Nucleotide sequences coding lyase for use as tool in identifying treatments which prevent or inhibit tumor cell metastasis, inflammation and autoimmunity |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142424 Transforming cells with genetically engineered phytic acid degrading enzyme for use in improving digestability and nutritional quality of animal feeds |
| 07/22/2004 | US20040142423 Novel polypeptides, DNAs encoding the same and use thereof |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142416 Treatment for phenylketonuria |
| 07/22/2004 | US20040142414 Production of heterologous protein in a minimal culture medium |
| 07/22/2004 | US20040142399 Recombinant FlaA as a diagnostic reagent |
| 07/22/2004 | US20040142395 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142390 Novel mammalian catecholamine receptor genes and uses |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142382 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement |
| 07/22/2004 | US20040142376 Deoxyribonuclease IIbeta proteins and cDNAs |
| 07/22/2004 | US20040142375 Nucleotide sequences coding cytidine deaminase for use as tool in diagnosis and treatment of cell proliferative disorders; enzyme inhibitors |
| 07/22/2004 | US20040142373 Measuring genome wide changes in gene expression profiles under various conditions; monitoring transcriptional alterations using high throughput assay; microarray analysis |
| 07/22/2004 | US20040142372 Comprises nucleotide sequences coding cytokine binding protein for use in identifying modulators for treatment of cell proliferative and inflammatory disorders |
| 07/22/2004 | US20040142369 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 07/22/2004 | US20040142364 Fungal transcriptional activator useful in methods for producing polypeptides |
| 07/22/2004 | US20040142359 Methods and compositions for treating neurological disorders |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142350 Nucleic acid molecule set for detecting Salmonella, nucleic acids, kit and use |
| 07/22/2004 | US20040142349 kit for detecting a risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142346 Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression |
| 07/22/2004 | US20040142343 can be used to raise an antibody or a binding portion thereof; may be used alone or combined with a pharmaceutically-acceptable carrier to induce a passive immunity |
| 07/22/2004 | US20040142340 comprising an array which has immobilised oligonucleotides represented on a surface support, wherein the oligonucleotides represented have a reactive-OH group at their free 3' end, and a means of extending said 3'-OH group; solid phase synthesis |
| 07/22/2004 | US20040142339 Methods for analysis of rna |
| 07/22/2004 | US20040142336 by recovering host/virus junction sequences from chimeric transcripts containing both host and virus sequences |
| 07/22/2004 | US20040142333 for diagnostics, biosensors, bioreactors, drug screening and therapy; genetic engineering |
| 07/22/2004 | US20040142332 Desaturase antigen of mycobacterium tuberculosis |
| 07/22/2004 | US20040142330 by subjecting a primer hybridized immediately adjacent to the target position using polymerase primer extension reaction; microarrays; solid phase synthesis; kits |
| 07/22/2004 | US20040142324 Method for extracting nucleic acids |
| 07/22/2004 | US20040142323 Nucleic acid-linked conjugates and methods for making and using them |
| 07/22/2004 | US20040142321 HCV assay |
| 07/22/2004 | US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance |
| 07/22/2004 | US20040142319 provide a hish speed/user-friendly alternative to haemagglutination-inhibition, fluorescent antibody and enzyme immunoassay, and reverse transcriptase polymerase chain reaction (RT-PCR); solid phase synthesis |
| 07/22/2004 | US20040142317 Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs |
| 07/22/2004 | US20040142095 Following immobilization of nucleic acid probes, functional groups with negative charge in an aqueous solution are generated by hydrolysing unreacted functional groups |
| 07/22/2004 | US20040142003 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 07/22/2004 | US20040142002 Recombinant poxvirus |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141980 Recombinant antibodies against infectious bursal disease virus (ibdv) |
| 07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
| 07/22/2004 | US20040141952 Death domain containing receptor 5 |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | DE10300649A1 Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Organismen Process for the preparation of ketocarotenoids by cultivation of genetically modified organisms |
| 07/22/2004 | DE10300335A1 Oxidoreduktase Oxidoreductase |
| 07/22/2004 | DE10260805A1 Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins Method and apparatus for optimizing a nucleotide sequence for expressing a protein |
| 07/22/2004 | DE10162867A1 New fusion protein and its complexes with nucleic acid, useful for treating solid tumors, comprises membrane-penetration and cell-damaging domains |
| 07/22/2004 | CA2522750A1 Immobilisation of dna-labelled lipid vesicles on dna arrays |
| 07/22/2004 | CA2514461A1 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 07/22/2004 | CA2512629A1 Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders |
| 07/22/2004 | CA2512365A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 07/22/2004 | CA2512196A1 Rolling circle amplification of rna |
| 07/22/2004 | CA2511824A1 Cell proliferation-related polypeptides and uses therefor |
| 07/22/2004 | CA2511820A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |
| 07/22/2004 | CA2511816A1 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | CA2511535A1 P53 treatment of papillomavirus and carcinogen-transformed cells in hyperplastic lesions |
| 07/22/2004 | CA2511315A1 Wound healing method and kits |
| 07/22/2004 | CA2509636A1 Rna interference |
| 07/22/2004 | CA2509378A1 Compositions and methods for nucleic acid extraction from biological samples |
| 07/22/2004 | CA2509337A1 Process for purification of plasmid dna |
| 07/22/2004 | CA2507882A1 Transgenic mice expressing human cd20 |
| 07/22/2004 | CA2507880A1 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | CA2507868A1 Stress-related polypeptides and uses therefor |
| 07/22/2004 | CA2507307A1 Increased production of secg protein in bacillus subtilis |
| 07/22/2004 | CA2503043A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2004 | EP1439235A1 Method of screening cell death inhibitor |
| 07/21/2004 | EP1439234A1 Targeted transgenesis using the rosa26 locus |
| 07/21/2004 | EP1439233A1 Polypeptides involved in floral development and genes encoding the same |
| 07/21/2004 | EP1439232A1 Method of elevating photosynthesis speed of plant by improving pyruvate phosphate dikinase |
| 07/21/2004 | EP1439231A2 Amino-terminally truncated rantes as chemokine antagonists |
| 07/21/2004 | EP1439230A2 Human transmembrane protein TMP-2 gene |
| 07/21/2004 | EP1439229A2 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 07/21/2004 | EP1439228A1 Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function |